Skip to main content

Table 2 Clinical data of the patients with Burkholderia capecia keratitis

From: Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series

 

Age/sex

Risk factor

Prior steroid use

Location, size

Hypopyon

Medical treatment

Surgery

Presenting VA

Final VA

Other isolates\

Matoba et al. [7]

59/m

HSV keratitis

+

C, M

-

Levofloxacin

-

CF

20/200

Enterococcus species, Staphylococcus aureus

Lin et al. [5]

16/f

Ortho-keratology lens

PC, S

Ciprofloxacin

20/40

20/20

Pseudomonas putida, Pseudomonas aeruginosa.

Ornek et al. [18]a

78/f

Cataract surgery

+

C, M

Ciprofloxacin +IVI

Ceftazidime

NLP

NA

 

Chaurasia et al. [4]

NA

Unknown

+

NA, M

Ciprofloxacin

Tissue adhesive

LP

NA

 
 

NA

Unknown

NA, S

+

Ciprofloxacin

NA

NA

 
 

NA

Trauma

NA, L

+

Ciprofloxacin

TPK

LP

NA

 
 

NA

TPK

+

NA, S

Ceftazidime

HM

NA

 

Reddy et al. [9]

27/m

LASIK

+

C, multiple infiltrates

+

Tobramycin and Gatifloxacin

 

CF

20/20

 
  1. central, CF  counting fingers, female, HM  hand motion, IVI  intravitreal injection, large, LASIK  laser assisted in situ keratomileusis, LP  light perception, male, medium, NA  not available, NLP  no light perception, PC  paracentral, small, TPK  therapeutic penetrating keratoplasty
  2. a A case of keratitis and endophthalmitis